Phase II data coming in second quarter Good data and I'm guessing buyout will soon follow. If 1mg and 2mg dose are potent enough to target NAFLD the buyout price is gonna surprise everyone. Madrigal data will also move Viking and if/when FDA grants Accelerated Approval it is going to be a big validation for this class of drug.
Market Data 
Markets 
AI
